高级搜索
Nm23基因和C-erb B-2基因表达与乳腺癌的预后[J]. 肿瘤防治研究, 1998, 25(3): 164-166.
引用本文: Nm23基因和C-erb B-2基因表达与乳腺癌的预后[J]. 肿瘤防治研究, 1998, 25(3): 164-166.
An evaluation of the prognostic significance of Nm23 and C-erb B-2 expression in breast cancers[J]. Cancer Research on Prevention and Treatment, 1998, 25(3): 164-166.
Citation: An evaluation of the prognostic significance of Nm23 and C-erb B-2 expression in breast cancers[J]. Cancer Research on Prevention and Treatment, 1998, 25(3): 164-166.

Nm23基因和C-erb B-2基因表达与乳腺癌的预后

An evaluation of the prognostic significance of Nm23 and C-erb B-2 expression in breast cancers

  • 摘要: 采用免疫组化SP法,探讨了Nm23基因和C-erbB-2因表达与乳腺癌诸临床病理参数和预后的关系。其中Nm23阳性表达率:64.l%,C-erbB-2性率:50.64%。二基因表达与患者年龄无相关性,Nm23表达与组织类型及临床分期无明显关系,而与淋巴结转移及术后生存期有明显关系;C-erbB-2表达与癌组织学类型、淋巴结、临床分期和术后生存期都有关系。

     

    Abstract: The present paper has investigated the prognostic significance of Nm23 and C-erb B-2expression in 156 patients with breast cancer utilizing immunohistochemical staining S-Pmethod. The results show that Nm23 positive expression rate is 64. I percent (100/156)andC-erb B-2 positive expression rate is 50. 64 percent (79/156). Both of Nm23 and C-erb B-2expression have no correlation with age of the patients. Nm23 expression has no significantrelation with the histological type and clinical stage,but significantly relates with lymph nodemetastasis and postoperation survival time, C-erb B-2 expression significantly relates withhistological type,lymph node metastasis,clinical stage and postoperation survival time.

     

/

返回文章
返回